| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377273A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 01/07/2004 | EP1377269A1 Encapsulated dyes in cosmetic compositions |
| 01/07/2004 | EP1377254A2 Cosmetic and dermatological preparations comprising an isoflavone content |
| 01/07/2004 | EP1377213A1 Method of predicting stroke evolution utilising mri |
| 01/07/2004 | EP1377181A1 Improved edible compositions for lowering cholesterol |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1289997B1 Macrolides |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1131101B1 Khellin preparation and the use thereof for topical therapy |
| 01/07/2004 | EP1103243B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives for the treatment of troubles mediated by an excess of substance p |
| 01/07/2004 | EP1098643B1 Phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate for the treatment of neoplastic diseases |
| 01/07/2004 | EP1082119B1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | EP1033988B1 Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP1015467B1 6,9-bridged erythromycin derivatives |
| 01/07/2004 | EP0973505B1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/07/2004 | EP0969846B1 Compositions and methods for reducing ocular hypertension |
| 01/07/2004 | EP0958285B1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES |
| 01/07/2004 | EP0954323B1 Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies |
| 01/07/2004 | EP0949925B1 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same |
| 01/07/2004 | EP0944611B1 Dimesylate salts of neuropeptide y ligands |
| 01/07/2004 | EP0935457B1 Preparation for the transport of an active substance across barriers |
| 01/07/2004 | EP0928301B1 Fluid composition for physiological separations |
| 01/07/2004 | EP0920326B1 Use of a bpi protein product as an antithrombotic agent |
| 01/07/2004 | EP0917457B1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 01/07/2004 | EP0909132B1 Dietetic baby food formula containing conjugated linoleic acids |
| 01/07/2004 | EP0785775B1 Melt-extruded orally administrable opioid formulations |
| 01/07/2004 | EP0748315B1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, these products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 01/07/2004 | EP0724436B1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466599A 聚合物水分散体 Aqueous polymer dispersion |
| 01/07/2004 | CN1466595A Grain fractionation methods and products |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466592A 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466590A Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 01/07/2004 | CN1466587A Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 01/07/2004 | CN1466585A Sodium sal ts of 5'-4'-2-(N-methyl-N-(2-pyridyl)amino) ethoxy [benzyl] thiazolidine-2,4-dione |
| 01/07/2004 | CN1466584A Tetrazolyl-phenyl acetamide glucokinase activators |
| 01/07/2004 | CN1466578A Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1466575A Quinolene derivatives as anti-inflammation agents |
| 01/07/2004 | CN1466570A Crystalline and pure modafinil and process of preparing the same |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/07/2004 | CN1466567A Substituted 1-aminobutan-3-01 derivatives |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466465A Preventives or remedies for obesity or fatty liver |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466460A Inhibition of systemic infectios in humans and vertebrates by dietary fibers |
| 01/07/2004 | CN1466459A 营养组合物 The nutritional composition |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466457A Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1466455A Fentanyl composition for nasal administration |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1466453A Fatty acid analogues for the treatment of proliferative skin disorders |
| 01/07/2004 | CN1466452A Composition for the transdermal delivery of fentanyl |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465583A 8-chloro-adenosine analogs, compositions containing said compound and use thereof |
| 01/07/2004 | CN1465582A Nucleotide analogs, medicinal compositions having same and use thereof |
| 01/07/2004 | CN1465574A L-nucleoside derivative and use thereof |
| 01/07/2004 | CN1465570A Process for preparing genistein, medicinal composition and use thereof |
| 01/07/2004 | CN1465567A Dihydropyridone derivative and use thereof |
| 01/07/2004 | CN1465566A Sinomenine Hydrochloride and its compound, synthesis and use |
| 01/07/2004 | CN1465406A Method for preparing tissue engineering cell scaffold and products obtained by said method |
| 01/07/2004 | CN1465384A Artificial bear gall and making method thereof |
| 01/07/2004 | CN1465382A Medicine for non-operation treating of hernia |
| 01/07/2004 | CN1465376A Medicinal composition containing zinc gluconate for resisting diplococcus pnenmonia |
| 01/07/2004 | CN1465348A Compound ablation mixture and application in preparing medicine for treating tumor |
| 01/07/2004 | CN1465347A Edible cellulose preparation |
| 01/07/2004 | CN1465346A Application of erychromycin lactobionate used as medicine for curing rhinitis and paranasual sinusitis |
| 01/07/2004 | CN1465345A Pure natural lecithin soft capsule and preparation method thereof |
| 01/07/2004 | CN1465344A Medicine composition for treating myocardial ischemia, angina pectoris and cardiac infarction |
| 01/07/2004 | CN1465343A Medical cure use of 17-allyl-4,5ÔÇÿalphaÔÇÖ-epoxy-3, 14-dihydroxymorphinan-6 keto hydrochloride |
| 01/07/2004 | CN1465342A Thiazolidine salt derivative hypoglycemic medicine |
| 01/07/2004 | CN1465341A Arginine acetate oral preparation and clinical application thereof |
| 01/07/2004 | CN1465338A Skin activating composition for external used anti-aging preparation |
| 01/07/2004 | CN1465285A Lead-removing health care food and preparation method thereof |
| 01/07/2004 | CN1133749C Process for preparing enantiomericaly enriched N-derivatised lactams |
| 01/07/2004 | CN1133654C Carboxynethylated derivative of ganoderic alpha-(1-3)-D-glucosan and its usage and preparing process |
| 01/07/2004 | CN1133653C Ganoderic alpha-(1-3)-D-glucosan sulfate derivative and its usage and preparing process |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133645C Antineoplastic compound intercedenside A |
| 01/07/2004 | CN1133643C Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives |
| 01/07/2004 | CN1133637C Triptolide analogs and composition and use thereof |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133635C Cyanopyrroles as progesterone receptor agonists |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/07/2004 | CN1133633C Method for prepn. of citalopram |
| 01/07/2004 | CN1133627C Intermediate of N-benzyl dioxothiazolidinyl benzoyl amide derivatives, and its prepn. method |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133623C Process for producing optically active imidazole compound, intermediates for synthesizing samke and mfg method |
| 01/07/2004 | CN1133622C Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/07/2004 | CN1133621C Cyclohexanediole derivatives |
| 01/07/2004 | CN1133612C Bamboo parasitic fungus extract and its preparation and application |
| 01/07/2004 | CN1133611C Substances capable of inducing appotosis |